Stock Research for CORT

Current Price


Latest Update: 2018-03-23 16:00:00

$ 16.7200
$ 16.7000
$ 16.7000

Featured Broker: TradeStation

Get the due diligence for another stock.


CORT Stock Chart & Research Data

The CORT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CORT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CORT Due diligence Resources & Stock Charts

The CORT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CORT Detailed Price Forecast - CNN Money CNN View CORT Detailed Summary - Google Finance
Yahoo View CORT Detailed Summary - Yahoo! Finance Zacks View CORT Stock Research & Analysis -

Stock Analysis

TradeIdeas View CORT Trends & Analysis - Trade-Ideas Barrons View CORT Major Holders - Barrons
NASDAQ View CORT Call Transcripts - NASDAQ Seeking View CORT Breaking News & Analysis - Seeking Alpha
Spotlight View CORT Annual Report - OTC Report View CORT OTC Short Report -
TradeKing View CORT Fundamentals - TradeKing Charts View CORT SEC Filings - Bar Chart
WSJ View Historical Prices for CORT - The WSJ Morningstar View Performance/Total Return for CORT - Morningstar
MarketWatch View the Analyst Estimates for CORT - MarketWatch CNBC View the Earnings History for CORT - CNBC
StockMarketWatch View the CORT Earnings - StockMarketWatch MacroAxis View CORT Buy or Sell Recommendations - MacroAxis
Bullish View the CORT Bullish Patterns - American Bulls Short Pains View CORT Short Pain Metrics -

Social Media Mentions

StockTwits View CORT Stock Mentions - StockTwits PennyStocks View CORT Stock Mentions - PennyStockTweets
Twitter View CORT Stock Mentions - Twitter Invest Hub View CORT Investment Forum News - Investor Hub
Yahoo View CORT Stock Mentions - Yahoo! Message Board Seeking Alpha View CORT Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CORT - Insider Cow View Insider Transactions for CORT - Insider Cow
CNBC View CORT Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CORT - OTC Markets
Yahoo View Insider Transactions for CORT - Yahoo! Finance NASDAQ View Institutional Holdings for CORT - NASDAQ

Stock Charts

FinViz View CORT Stock Insight & Charts - StockCharts View CORT Investment Charts -
BarChart View CORT Stock Overview & Charts - BarChart Trading View View CORT User Generated Charts - Trading View

Latest Financial News for CORT

Edited Transcript of CORT earnings conference call or presentation 22-Feb-18 10:00pm GMT
Posted on Friday March 23, 2018

Q4 2017 Corcept Therapeutics Inc Earnings Call

Teva Sued by Corcept Therapeutics over Patent Infringement Claim
Posted on Wednesday March 21, 2018

The company announced that it had filed the case in the United States District Court for the District of New Jersey for its Korlym (mifepristone) 300 mg tablet patent. On the day, TEVA stock registered a fall of ~3%, and Corcept Therapeutics stock fell ~0.6%. The suit was filed by Corcept after Teva filed an ANDA (Abbreviated New Drug Application) for FDA approval for selling and marketing a generic version of Korlym.

Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents
Posted on Thursday March 15, 2018

MENLO PARK, Calif., March 15, 2018-- Corcept Therapeutics Incorporated, a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and psychiatric ...

Why Corcept Therapeutics Incorporated Lost 34% in February
Posted on Monday March 12, 2018

Corcept's share price took a big hit following news that its core product may face generic competition sooner than anticipated.

Warning: DOMDocument::load(): StartTag: invalid element name in, line: 1 in /home/allsites/ on line 494

Warning: DOMDocument::load(): Extra content at the end of the document in, line: 1 in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.